ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1808

Tobacco Smoking Reduces the Incidence and Delays the Progression of Knee Osteoarthritis: 10-year Retrospective Cohort Study Based on Korea National Health Insurance Service-Health Screening Database

Junyong Park1, Minkook Son2, Sang Yeob Lee1, Wontae Chung1 and SungWon Lee1, 1Dong-A University Hospital, Busan, South Korea, 2Dong-A University, Busan, South Korea

Meeting: ACR Convergence 2023

Keywords: Epidemiology, Osteoarthritis, surgery

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1796–1826) Epidemiology & Public Health Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: There are conflicting results about relationship between smoking and incidence of knee osteoarthritis (OA). The effect of smoking to preexisting knee OA has also not been addressed in detail. To address these issues, we designed a retrospective cohort study to investigate the relationship between smoking and knee OA, based on a large-scale claim database from Korea.

Methods: The Korea National Health Insurance Service-Health Screening database is registered with 98% of Koreans and includes all insurance claims. From this database, two retrospective cohort study were conducted. The operational definition of diagnosis of knee osteoarthritis was knee osteoarthritis code (M17) or any site of osteoarthritis code (M15 to M19) along with a knee x-ray (G720, G721). In OA incidence study, the diagnosis of knee osteoarthritis was set as a primary endpoint on OA-naïve people. In OA progression study, we hypothesized that knee replacement surgery is a surrogate marker for progression of knee OA. Thus in OA progression study, the primary endpoint was set as knee replacement surgery (N2072, N2077, N2712, N2717) among previously diagnosed knee OA patients. The study populations were followed from the day of health screening at index year to primary endpoint, the date of death, or December 31, 2019, whichever comes first.

Results: The patient group was classified into non-smoker, ex-smoker, and smoker groups according to the responses to the health examination questionnaire. The baseline characteristics of each group in incidence study and progression study are included in Table 1 and Table 2. The incidence of knee OA was 38.9%, 26%, and 23% in each group of non-smoker, ex-smoker, and smoker group with statistical significance (P-value < 0.001). When the disease-free probability for knee OA was presented using the Kaplan-Meier curve, the risk of knee OA incidence was significantly different between the non-smoker group and the smoker group over time (Figure 1A). The hazard ratio of ex-smoker to non-smoker were 0.95 (0.83-0.97), and those of smoker to non-smoker were 0.89 (0.87-0.91). In knee OA progression study, the frequency of knee replacement surgery due to OA was 5.3% among non-smokers, 2.3% among ex-smokers, and 2.1% among smokers. The Kaplan-Meier curve of knee OA progression study showed that the knee replacement surgery in non-smoker group was more frequent than ex-smoker group and non-smoker group as time passed (Figure 1B). The adjusted hazard ratio of ex-smoker to non-smoker were 0.81 (0.66-0.99, p=0.04) and those of smoker to non-smoker were 0.76 (0.61-0.96, p=0.02).

Conclusion: This large-scale retrospective cohort study revealed that both incidence and frequency of knee replacement surgery, one of the indicators of progression of knee osteoarthritis, was lower in smoker group and ex-smoker group than in non-smoker group. Further studies on exact mechanism of smoking and osteoarthritis are required.

Supporting image 1

Table 1. Baseline characteristics of knee OA incidence study population

Supporting image 2

Table 2. Baseline characteristics of knee OA progression study population

Supporting image 3

Figure 1. The Kaplan Meyer(K-M) curve of each studies. (A) K-M curve of knee OA incidence study. (B) K-M curve of knee OA progression study.


Disclosures: J. Park: None; M. Son: None; S. Lee: None; W. Chung: None; S. Lee: None.

To cite this abstract in AMA style:

Park J, Son M, Lee S, Chung W, Lee S. Tobacco Smoking Reduces the Incidence and Delays the Progression of Knee Osteoarthritis: 10-year Retrospective Cohort Study Based on Korea National Health Insurance Service-Health Screening Database [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/tobacco-smoking-reduces-the-incidence-and-delays-the-progression-of-knee-osteoarthritis-10-year-retrospective-cohort-study-based-on-korea-national-health-insurance-service-health-screening-database/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/tobacco-smoking-reduces-the-incidence-and-delays-the-progression-of-knee-osteoarthritis-10-year-retrospective-cohort-study-based-on-korea-national-health-insurance-service-health-screening-database/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology